Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial.

Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial. Neurosurgery. 2017 Nov 01; 81(5):860-866.

View in: PubMed

subject areas

Adult
Catheters
Cerebral Hemorrhage
Combined Modality Therapy
Female
Fibrinolytic Agents
Hematoma
Humans
Male
Minimally Invasive Surgical Procedures
Prospective Studies
Tissue Plasminogen Activator
Treatment Outcome

authors with profiles

Issam Awad
Romuald Girard